General Information of the Compound
| Compound ID |
CP0049004
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid;hydrate
Show/Hide
|
||||||||||||||||||
| Synonyms |
(1S,3R)-1-ACPD
(1S,3R)-ACPD
(1S,3S)-ACPD
1S,3R-ACPD
trans-ACPD
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C7H11NO4
|
||||||||||||||||||
| Molecular Weight |
173.168
|
||||||||||||||||||
| Canonical SMILES |
N[C@]1(CC[C@H](C1)C(O)=O)C(O)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C7H11NO4/c8-7(6(11)12)2-1-4(3-7)5(9)10/h4H,1-3,8H2,(H,9,10)(H,11,12)/t4-,7+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
YFYNOWXBIBKGHB-FBCQKBJTSA-N
|
||||||||||||||||||
| CAS |
111900-32-4
130942-93-7
149881-50-5
27-84-9
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01994, Metabotropic glutamate receptor 1
Protein ID: PT01748, Metabotropic glutamate receptor 2
Protein ID: PT02446, Metabotropic glutamate receptor 4
Clinical Information about the Compound
Drug 1 ( (1S,3R)-ACPD )
| Drug Name | (1S,3R)-ACPD | ||
|---|---|---|---|
| Target(s) | |||